Three tickers for capital gains

Most Traders Will Be Rummaging  To Find Trades On Monday   Jason Bond On The Other Hand  Will Be Peeling Off Profits All Thanks To This Weekend Strategy Watch Now Hello trader, Wow, what a wild start to May. The S&P 500 and Nasdaq finished lower by 2.81% and 3.20% respectively. With so much action and volatility in the market, I think there will be a lot of favorable opportunities out there for me to take advantage of. Today, I want to reveal a mergers and acquisitions (M&A) strategy that some hedge funds out there use… and it's known as merger arbitrage. It's a type of event-driven trading strategy. Don't get scared off by that term because I'm going to break it down, and show an alternative strategy to potentially play an M&A stock currently on my radar.   Click here to continue reading...   Kyle Dennis The People's Trader    Remove me from Biotech Breakouts Free Newsletter  Click here to unsubscribe and stop receiving exclusive emails from kyle@biotechbreakouts.com Neither Kyle Dennis nor RagingBull.com, LLC (publisher of BiotechBreakouts) is registered as an investment adviser nor a broker/dealer with either the U. S. Securities & Exchange Commission or any state securities regulatory authority. Users of this website are advised that all information presented on this website is solely for informational purposes, is not intended to be used as a personalized investment recommendation, and is not attuned to any specific portfolio or to any user's particular investment needs or objectives. The owners, employees and writers of RagingBull.com may engage in securities trading that is discussed or viewed on this website, but all such individuals are buying and selling such securities for their own account. These individuals do not engage in any trades with customers. The buying and selling of securities by these individuals is not part of a regular business of buying and selling securities. Past performance is NOT indicative of future results. Furthermore, such information is not to be construed as an offer to sell or the solicitation of an offer to buy, nor is it to be construed as a recommendation to buy, hold or sell (short or otherwise) any security. All users of this website must determine for themselves what specific investments to make or not make and are urged to consult with their own independent financial advisors with respect to any investment decision. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. All opinions, analyses and information included on this website are based on sources believed to be reliable and written in good faith, but should be independently verified, and no representation or warranty of any kind, express or implied, is made, including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. In addition, we undertake no responsibility to notify such opinions, analyses or information or to keep such opinions, analyses or information current. Also be aware that owners, employees and writers of and for RagingBull.com, LLC may have long or short positions in securities that may be discussed on this website or newsletter, but all such positions are held for such representative's own account. Past results are not indicative of future profits. This table is accurate, though not every trade is represented. Profits and losses reported are actual figures from the portfolios Kyle Dennis manages on behalf of RagingBull.com, LLC. If you have a current active subscription with Biotech Breakouts you will need to contact us here if you want to cancel your subscription. Opting out of emails does not remove you from your service at BiotechBreakouts.com.    Unsubscribe from all RagingBull Emails

62 Calef Hwy #233 Lee, New Hampshire 03861 United States